These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 20649877

  • 1. Decrease in cell proliferation by an matrix metalloproteinase inhibitor, doxycycline, in a model of immune-complex nephritis.
    Saglam F, Celik A, Tayfur D, Cavdar Z, Yilmaz O, Sarioglu S, Kolatan E, Oktay G, Camsari T.
    Nephrology (Carlton); 2010 Aug; 15(5):560-7. PubMed ID: 20649877
    [Abstract] [Full Text] [Related]

  • 2. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
    Mitani O, Katoh M, Shigematsu H.
    Pathol Int; 2004 Apr; 54(4):241-50. PubMed ID: 15028025
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P.
    Nephrol Dial Transplant; 2007 Apr 02; 22(4):1115-22. PubMed ID: 17205957
    [Abstract] [Full Text] [Related]

  • 9. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
    Urushihara M, Kagami S, Kuhara T, Tamaki T, Kuroda Y.
    Nephrol Dial Transplant; 2002 Jul 02; 17(7):1189-96. PubMed ID: 12105240
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 02; 27(1):53-61. PubMed ID: 15782494
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT, Khan SB, Allen A, Bhangal G, Smith J, Lobb RR, Pusey CD.
    Am J Pathol; 2002 Oct 02; 161(4):1265-72. PubMed ID: 12368200
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May 02; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 15. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
    Claveau I, Mostefaoui Y, Rouabhia M.
    Matrix Biol; 2004 Nov 02; 23(7):477-86. PubMed ID: 15579314
    [Abstract] [Full Text] [Related]

  • 16. Treatment of experimental immune complex glomerulonephritis by sodium alginate.
    Mirshafiey A, Borzooy Z, Abhari RS, Razavi A, Tavangar M, Rehm BH.
    Vascul Pharmacol; 2005 Jun 02; 43(1):30-5. PubMed ID: 15893960
    [Abstract] [Full Text] [Related]

  • 17. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, Fenoglio C, Perlini S, Pozzi E.
    Eur J Histochem; 2006 Jun 02; 50(4):317-25. PubMed ID: 17213041
    [Abstract] [Full Text] [Related]

  • 18. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
    Sanders JS, van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA.
    Nephrol Dial Transplant; 2004 Jun 02; 19(6):1412-9. PubMed ID: 15034162
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
    Schaefer L, Han X, August C, Matzkies F, Lorenz T, Schaefer RM.
    Diabetologia; 1997 Sep 02; 40(9):1035-43. PubMed ID: 9300240
    [Abstract] [Full Text] [Related]

  • 20. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD, Yoon WH.
    BMC Cancer; 2006 Aug 18; 6():211. PubMed ID: 16916471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.